Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27397005 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL27264197 | 1.00 | — | — | |
| Methane SCHEMBL28777825 | 0.97 | ALDH1A1 (0.53) | — | |
| SCHEMBL3674 | 0.97 | — | — | |
| SCHEMBL29697593 | 0.97 | ALDH1A1 (0.59) | — | |
| Bicarbonate SCHEMBL895901 | 0.93 | ALDH1A1 (0.56) | — | |
| SCHEMBL16444754 | 0.93 | — | — | |
| SCHEMBL2527643 | 0.93 | — | — | |
| Water SCHEMBL21436717 | 0.93 | ALDH1A1 (0.56) | — | |
| Water SCHEMBL22362220 | 0.93 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2590634-A2 | COMBINATION IMMEDIATE/DELAYED RELEASE DELIVERY SYSTEM FOR SHORT HALF-LIFE PHARMACEUTICALS INCLUDING REMOGLIFLOZIN | BHV Pharma, Inc. (US) | 2013-05-15 | — | — | EP | claimed |
| WO-2012006398-A2 | COMBINATION IMMEDIATE/DELAYED RELEASE DELIVERY SYSTEM FOR SHORT HALF-LIFE PHARMACEUTICALS INCLUDING REMOGLIFLOZIN | BHV PHARMA, INC. (US) | 2012-01-12 | — | — | WO | claimed |
| WO-1991017172-A1 | NOVEL MYCALAMIDES WITH ANTITUMOR AND ANTIVIRAL ACTIVITY | HARBOR BRANCH OCEANOGRAPHIC INSTITUTION, INC. (US) | 1991-11-14 | — | — | WO | claimed |
| CN-116351354-A | Down-flow photochlorination continuous reaction equipment and method | 上海化工研究院有限公司 | 2023-06-30 | — | — | CN | disclosed |
| CN-116351355-A | Overflow tower type photochlorination reactor and method | 上海化工研究院有限公司 | 2023-06-30 | — | — | CN | disclosed |
| CN-107438599-B | Targeted Notch pathway inhibitors | 豪夫迈·罗氏有限公司 | 2021-12-10 | — | — | CN | disclosed |
| US-10940159-B2 | Combination immediate/delayed release delivery system for short half-life pharmaceuticals including remogliflozin | ISLET SCIENCES | 2021-03-09 | — | — | US | disclosed |
| CN-107438599-A | TARGETED NOTCH PATHWAY INHIBITORS | 豪夫迈·罗氏有限公司 | 2017-12-05 | — | — | CN | disclosed |
| CN-104662004-B | Novel rebamipide prodrug, method for producing same, and usage thereof | 三进制药株式会社 | 2017-04-19 | — | — | CN | disclosed |
| EP-2590634-B1 | COMBINATION IMMEDIATE/DELAYED RELEASE DELIVERY SYSTEM FOR SHORT HALF-LIFE PHARMACEUTICALS INCLUDING REMOGLIFLOZIN | BHV PHARMA INC (US) | 2016-03-09 | — | — | EP | disclosed |
| CN-101884629-B | Controlled release preparation | TAKEDA PHARMACEUTICAL | 2013-08-21 | — | — | CN | disclosed |
| WO-2012006398-A2 | COMBINATION IMMEDIATE/DELAYED RELEASE DELIVERY SYSTEM FOR SHORT HALF-LIFE PHARMACEUTICALS INCLUDING REMOGLIFLOZIN | BHV PHARMA, INC. (US) | 2012-01-12 | — | — | WO | disclosed |
| CN-102149385-A | Compound (I) | GLAXOSMITHKLINE LLC | 2011-08-10 | — | — | CN | disclosed |
| CN-101884629-A | Controlled release preparation | TAKEDA PHARMACEUTICAL | 2010-11-17 | — | — | CN | disclosed |
| CN-101641353-A | Novel compounds for treatment of psychotic disorders, preparation methods and uses thereof | YOUXIN LI | 2010-02-03 | — | — | CN | disclosed |
| CN-1713897-A | Controlled release formulations | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2005-12-28 | — | — | CN | disclosed |
| CN-1678315-A | Prodrugs of imidazole derivatives as proton pump inhibitors for the treatment of e.g. peptic ulcers | TAKEDA PHARMACEUTICAL (JP) | 2005-10-05 | — | — | CN | disclosed |
| EP-0511347-A1 | META-SUBSTITUTED PHENYL ALANINE DERIVATIVES | Pentapharm A.G. (CH) | 1992-11-04 | — | — | EP | disclosed |
| WO-1992008709-A1 | META-SUBSTITUTED PHENYL ALANINE DERIVATIVES | PENTAPHARM AG (CH) | 1992-05-29 | — | — | WO | disclosed |
| US-3989710-A | POSTEMERGENCE HERBICIDES | BAYER AKTIENGESELLSCHAFT (DT) | 1976-11-02 | — | — | US | disclosed |